GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predictive Oncology Inc (FRA:S1K) » Definitions » E10

Predictive Oncology (FRA:S1K) E10 : €0.00 (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Predictive Oncology E10?

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Predictive Oncology's adjusted earnings per share data for the three months ended in Mar. 2024 was €0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €0.00 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average E10 Growth Rate was 46.90% per year. During the past 5 years, the average E10 Growth Rate was 39.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Predictive Oncology was 46.90% per year. The lowest was 33.10% per year. And the median was 37.70% per year.

As of today (2024-06-25), Predictive Oncology's current stock price is €4.00. Predictive Oncology's E10 for the quarter that ended in Mar. 2024 was €0.00. Predictive Oncology's Shiller PE Ratio of today is .


Predictive Oncology E10 Historical Data

The historical data trend for Predictive Oncology's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predictive Oncology E10 Chart

Predictive Oncology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -18,048.50 -11,592.90 -8,418.33 -4,673.23 -

Predictive Oncology Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,154.55 -3,048.70 -3,554.53 - -

Competitive Comparison of Predictive Oncology's E10

For the Medical Instruments & Supplies subindustry, Predictive Oncology's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Predictive Oncology's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Predictive Oncology's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Predictive Oncology's Shiller PE Ratio falls into.



Predictive Oncology E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Predictive Oncology's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.7762*131.7762
=0.000

Current CPI (Mar. 2024) = 131.7762.

Predictive Oncology Quarterly Data

per share eps CPI Adj_EPS
201406 -2,150.945 100.560 -2,818.663
201409 -1,444.757 100.428 -1,895.736
201412 -3,104.102 99.070 -4,128.879
201503 -332.221 99.621 -439.453
201506 -1,595.353 100.684 -2,088.016
201509 -956.453 100.392 -1,255.462
201512 -1,995.622 99.792 -2,635.226
201603 -540.596 100.470 -709.042
201606 -169.100 101.688 -219.134
201609 -57.024 101.861 -73.771
201612 -30.438 101.863 -39.377
201703 -39.270 102.862 -50.309
201706 -72.980 103.349 -93.054
201709 -26.848 104.136 -33.974
201712 -27.040 104.011 -34.258
201803 -24.330 105.290 -30.450
201806 -34.240 106.317 -42.439
201809 -32.395 106.507 -40.081
201812 -42.544 105.998 -52.891
201903 -36.993 107.251 -45.452
201906 4.248 108.070 5.180
201909 -23.790 108.329 -28.939
201912 -81.720 108.420 -99.324
202003 -16.833 108.902 -20.369
202006 -6.394 108.767 -7.747
202009 -7.811 109.815 -9.373
202012 -9.521 109.897 -11.417
202103 -1.848 111.754 -2.179
202106 -0.830 114.631 -0.954
202109 -1.360 115.734 -1.549
202112 -2.301 117.630 -2.578
202203 -0.926 121.301 -1.006
202206 -2.734 125.017 -2.882
202209 -1.050 125.227 -1.105
202212 -1.935 125.222 -2.036
202303 -0.803 127.348 -0.831
202306 -0.905 128.729 -0.926
202309 -0.731 129.860 -0.742
202312 0.000 129.419 0.000
202403 0.000 131.776 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Predictive Oncology  (FRA:S1K) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Predictive Oncology E10 Related Terms

Thank you for viewing the detailed overview of Predictive Oncology's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Predictive Oncology (FRA:S1K) Business Description

Traded in Other Exchanges
Address
2915 Commers Drive, Suite 900, Eagan, MN, USA, 55121
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Helomics, zPREDICTA, Soluble and Skyline. It derives prime revenue from the Skyline segment which consists of the STREAMWAY System product sales, and TumorGenesis subsidiary (Research and Development) is included within corporate. The STREAMWAY System virtually eliminates staff exposure to blood, irrigation fluid, and other potentially infectious fluids found in the healthcare environment. Its Helomics division is focused on improving the effectiveness of cancer therapy using proprietary, multi-omic tumor profiling platform, a one-of-a-kind database of historical tumor data, and the power of AI to build predictive models of tumor drug response.

Predictive Oncology (FRA:S1K) Headlines

No Headlines